Concepedia

Angeliki Ioannidis

AI

6

Publications

187

Citations

6

H-Index

2020

Active since

Affiliations

University of California, Los Angeles(Current)

UCLA Jonsson Comprehensive Cancer Center

Stanford University

University of Freiburg

Nuffield Orthopaedic Centre

Angeliki Ioannidis is an author at University of California, Los Angeles specializing in medicine, epidemiology, and covid-19 epidemiology.

ORCID

Top concepts

Publications per year

2020–2021

6

Publications

6

The worldwide clinical trial research response to the COVID-19 pandemic - the first 100 days

Perrine Janiaud, Cathrine Axfors, Janneke van ’t Hooft et al. · F1000Research · 2020 · 54 citations · Full text

The worldwide clinical trial research response to the COVID-19 pandemic - the first 100 days

Perrine Janiaud, Cathrine Axfors, Janneke van ’t Hooft et al. · F1000Research · 2020 · 45 citations · Full text

, , +15

Dopamine Receptor Antagonists, Radiation, and Cholesterol Biosynthesis in Mouse Models of Glioblastoma

Kruttika Bhat, Mohammad Saki, Fei Cheng et al. · JNCI Journal of the National Cancer Institute · 2021 · 37 citations · Full text

Effects of the DRD2/3 antagonist ONC201 and radiation in glioblastoma

Ling He, Kruttika Bhat, Angeliki Ioannidis et al. · Radiotherapy and Oncology · 2021 · 22 citations · Full text

, , +9

1-[(4-Nitrophenyl)sulfonyl]-4-phenylpiperazine treatment after brain irradiation preserves cognitive function in mice

Kruttika Bhat, Paul Mark B. Medina, Ling He et al. · Neuro-Oncology · 2020 · 19 citations · Full text

Rows per page

1–5 of 6